GleamWall
中文EN

CRDL Cardiol Therapeutics Inc. IFRS Annual reports only

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1702123 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY7.8%
TTM EPS YoY23.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-158.8%
ROA-121.9%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets24.3%
Debt / equity0.00x
Current ratio4.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-35.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue——
R&D expense14.02M14.01M
SG&A expense20.30M26.26M
Operating income-34.32M-40.28M
Net income-33.82M-36.68M
EPS (basic)-0.39-0.51
EPS (diluted)-0.39-0.51
Weighted avg. shares (diluted)86.99M71.57M
Balance sheet
Cash & equivalents21.42M30.58M
Receivables55,727100,366
Current assets23.50M31.67M
PP&E, netmay include right-of-use assets (IFRS)118,093195,592
Total assets23.62M31.86M
Current liabilities5.66M7.01M
Total liabilities5.74M7.14M
Shareholders' equity17.88M24.73M
Cash flow statement
Operating cash flow-23.85M-25.06M
Capital expenditure24,48421,290
Free cash flow-23.88M-25.08M
Investing cash flow-24,484-21,290
Financing cash flow15.54M18.84M
Stock-based compensation10.70M14.28M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.